Projects per year
Personal profile
Expertise
- Research for therapies, targeting the myeloma cell in its microenvironment
Fingerprint
Dive into the research topics where Eline Menu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Projects
-
OZR3593: Bilateral cooperation within the framework of a joint doctoral project: benchfee for joint PhD VUB - NPU, WANG Fang
22/06/20 → 21/06/24
Project: Fundamental
-
OZR3565: Seahorse platform: the Agilent Seahorse Flux Analyser with integrated normalization system
Massie, A., Stiens, J., Van Ginderachter, J., Vanommeslaeghe, K., Vinken, M., Menu, E., Spits, C. & Njemini, R.
1/05/20 → 30/04/24
Project: Fundamental
-
HERC53: Seahorse platform: the Agilent Seahorse Flux Analyser with integrated normalization system
Massie, A., Stiens, J., Van Ginderachter, J., Vanommeslaeghe, K., Vinken, M., Menu, E., Spits, C. & Njemini, R.
1/05/20 → 30/04/24
Project: Fundamental
-
FWOTM970: Targeting the hypoxia-induced metabolic changes in multiple myeloma to conquer drug resistance.
1/10/19 → 31/10/21
Project: Fundamental
-
AIIFUND26: Metabolism within the bone marrow microenvironment: targets for MM therapy?
1/01/18 → 31/12/18
Project: Fundamental
Research output
-
A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma
Nylund, P., Atienza Párraga, A., Haglöf, J., De Bruyne, E., Menu, E., Garrido-Zabala, B., Ma, A., Jin, J., Öberg, F., Vanderkerken, K., Kalushkova, A. & Jernberg-Wiklund, H., 12 Feb 2021, In : Cell & Death Disease. 12, 2, 16 p., 167.Research output: Contribution to journal › Article
-
Targeting phosphoglycerate dehydrogenase in multiple myeloma
Elsaadi, S., Steiro, I., Abdollahi, P., Vandsemb, E. N., Yang, R., Slørdahl, T. S., Rø, T. B., Menu, E., Sponaas, A-M. & Børset, M., 4 Jan 2021, In : Experimental Hematology and Oncology. 10, 1, 13 p., 3.Research output: Contribution to journal › Article
1 Citation (Scopus) -
AXL: A potential therapeutic target to eliminate cancer cells and improve chemotherapeutic responses in different hematological cancers
Vlummens, P., De Beule, N., Faict, S., Oudaert, I., Maes, K., De Bruyne, E., Menu, E., Vanderkerken, K. & De Veirman, K., 14 Feb 2020, In : Belgian Journal of Hematology. 11, O2, p. 9-9 1 p., 11.Research output: Contribution to journal › Meeting abstract (Journal)
-
Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade
Yang, R., Elsaadi, S., Misund, K., Abdollahi, P., Vandsemb, E. N., Moen, S. H., Kusnierczyk, A., Slupphaug, G., Standal, T., Waage, A., Slørdahl, T. S., Rø, T. B., Rustad, E., Sundan, A., Hay, C., Cooper, Z., Schuller, A. G., Woessner, R., Borodovsky, A., Menu, E. & 2 others, , May 2020, In : Journal for immunotherapy of cancer. 8, 1, 14 p., e000610.Research output: Contribution to journal › Article
8 Citations (Scopus) -
Identification of the immune checkpoint signature of multiple myeloma using mass cytometry-based single-cell analysis
Wang, J., Zheng, Y., Tu, C., Zhang, H., Vanderkerken, K., Menu, E. & Liu, J., May 2020, In : Clinical & translational immunology. 9, 5, e1132.Research output: Contribution to journal › Article
2 Citations (Scopus)
Prizes
-
-
TARGETING MONOCARBOXYLATE TRANSPORTER 4 REDUCES MYELOMA CELL VIABILITY IN VITRO
Inge Oudaert (Recipient), Eline Menu (Recipient) & Lauren Van Droogenbroeck (Recipient), 3 Mar 2021
Prize: Prize (including medals and awards)
-
Targeting of pyrroline-5-carboxylate reductase (PYCR) reduces drug resistance in multiple myeloma in vitro.
Inge Oudaert (Recipient) & Eline Menu (Recipient), 29 Jan 2021
Prize: Prize (including medals and awards)
Activities
-
TARGETING MONOCARBOXYLATE TRANSPORTER 4 REDUCES MYELOMA CELL VIABILITY IN VITRO
Inge Oudaert (Contributor), Eline Menu (Presenter), Lauren Van Droogenbroeck (Presenter)3 Mar 2021 → 6 Mar 2021Activity: Talk or presentation › Talk or presentation at a conference
-
Targeting of pyrroline-5-carboxylate reductase (PYCR) reduces drug resistance in multiple myeloma in vitro.
Inge Oudaert (Speaker), Eline Menu (Contributor), Kim De Veirman (Contributor)29 Jan 2021 → 30 Jan 2021Activity: Talk or presentation › Talk or presentation at a conference
-
The role of exosomes in Multiple Myeloma development & Drug Resistance
Eline Menu (Speaker)20 Sep 2019Activity: Talk or presentation › Talk at an external academic organisation
-
Belgian Society for Extracellular Vesicles (External organisation)
Eline Menu (Member)2019 → …Activity: Membership › Membership of public/government advisory/policy group or panel
-
MCL1 Inhibitors in Multiple Myeloma
Kim De Veirman (Contributor), Karin Vanderkerken (Speaker), Elke De Bruyne (Contributor), Eline Menu (Contributor)13 Nov 2019Activity: Talk or presentation › Talk or presentation at a conference
Press / Media
-
Opmerkelijke doorbraak in strijd tegen multipel myeloom
1/01/05
1 Media contribution
Press/Media: Other
-
-
-
-
Thesis
-
ASPIRE: adjuvant-driven induction of cancer Specific Immune Responses
Author: Van Der Jeught, K., Breckpot, K., Thielemans, K., Vanderkerken, K., Menu, E., van Grunsven, L. A., Pascolo, S. & Raemdonck, K., 20 Oct 2016Supervisor: Breckpot, K. (Promotor), Thielemans, K. (Promotor), Vanderkerken, K. (Jury), Van Grunsven, L. A. (Jury), Menu, E. (Jury), Van Raemdonck, K. (External person) (Jury) & Pascolo, S. (External person) (Jury)
Student thesis: Doctoral Thesis
-
Biological and clinical implications of invariant natural killer T cells in multiple myeloma: rising the potential for immunotherapy
Author: Nur, H., Menu, E. & Vanderkerken, K., 17 Sep 2014Supervisor: Menu, E. (Promotor) & Vanderkerken, K. (Promotor)
Student thesis: Doctoral Thesis
-
Bone marrow-induced survival: identifying novel targets in multiple myeloma.
Author: De Beule, N., Vanderkerken, K., Schots, H., Menu, E., Van Valckenborgh, E., Neyns, B., Van Riet, I., Laoui, D., Pals, S. & Offner, F., 24 Apr 2018Supervisor: Vanderkerken, K. (Promotor), Schots, H. (Promotor), Menu, E. (Promotor), Van Valckenborgh, E. (Promotor), Neyns, B. (Jury), Van Riet, I. (Jury), Laoui, D. (Jury), Pals, S. (External person) (Jury) & Offner, F. (External person) (Jury)
Student thesis: Doctoral Thesis
-
Evaluating single domain antibodies specific for PD-L1 as cancer nuclear imaging and therapy agents
Author: Broos, K., Breckpot, K., Devoogdt, N., Keyaerts, M., De Gruijl, T., Vermaelen, K., Everaert, H., Menu, E. & Neyns, B., 11 Oct 2019Supervisor: Breckpot, K. (Promotor), Devoogdt, N. (Promotor), Keyaerts, M. (Promotor), De Gruijl, T. (External person) (Jury), Vermaelen, K. (External person) (Jury), Everaert, H. (Jury), Menu, E. (Jury) & Neyns, B. (Jury)
Student thesis: Doctoral Thesis
-
Evaluation of α-galactosylceramide loaded dexosomes as immune therapy in multiple myeloma
Author: Favreau, M. & Moens, C. H., 2016Supervisor: Menu, E. (Promotor)
Student thesis: Master's Thesis